Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totaling 111,907 shares, a growth of 1,048.7% from the August 31st total of 9,742 shares. Based on an average daily volume of 81,381 shares, the days-to-cover ratio is currently 1.4 days.

Ono Pharmaceutical Stock Up 1.0%

OPHLY stock traded up $0.05 on Friday, hitting $5.19. 39,387 shares of the company’s stock were exchanged, compared to its average volume of 35,346. The firm has a 50 day moving average price of $5.04 and a two-hundred day moving average price of $4.99. Ono Pharmaceutical has a 12-month low of $3.71 and a 12-month high of $5.75.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd. is a Japan-based research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its principal focus areas include oncology, immunology, neurology and other specialty diseases, with an emphasis on innovative treatments for conditions with significant unmet medical needs.

The company is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used in the treatment of multiple types of cancer.